ACTU — ACTUATE THERAPEUTICS INC
As of Q2 2026, 14 SEC-registered investment managers reported holding ACTU (ACTUATE THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $794.47K across 519.01K shares. That is -41.8% by share count (-373.12K shares) versus the previous quarter, while reported value moved -67.5%. Ownership is concentrated: the five largest holders account for 89.0% of reported value and the top ten for 98.3%.
Compared with the prior quarter, 2 opened new positions, 4 added to existing stakes, 8 trimmed, 4 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
ACTU is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 529.11K | $3.24M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 127.49K | $195.06K | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 112.55K | $172.21K | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 96.68K | $147.93K | 0.00% | New |
| BlackRock Inc history | Q2 2026 | 90.03K | $137.75K | 0.00% | Reduce |
| Marshall Wace history | Q1 2025 | 16.11K | $109.09K | 0.00% | New |
| Citadel Advisors history | Q1 2025 | 14.19K | $96.03K | 0.00% | New |
| Goldman Sachs Group history | Q2 2026 | 35.50K | $54.31K | 0.00% | Add |
| BNY Mellon history | Q1 2026 | 15.42K | $42.24K | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 21.22K | $32.47K | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q1 2026 | 11.15K | $30.54K | 0.00% | Reduce |
| Bank of America Corp history | Q1 2026 | 11.03K | $30.23K | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 12.23K | $18.72K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 7.63K | $12.05K | 0.00% | New |
| UBS Group AG history | Q2 2026 | 3.53K | $5.41K | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 3.49K | $5.34K | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 3.29K | $5.03K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 2.51K | $3.85K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 2.45K | $3.74K | 0.00% | Reduce |
| Legal & General Investment Management America history | Q1 2026 | 1.11K | $3.03K | 0.00% | Reduce |
New Positions (Q2 2026)
- Millennium Management 96.68K sh · $147.93K
- JPMorgan Chase & Co 7.63K sh · $12.05K
Fully Exited (vs previous quarter)
- BNY Mellon sold 15.42K sh · $42.24K
- Charles Schwab Investment Management sold 11.15K sh · $30.54K
- Bank of America Corp sold 11.03K sh · $30.23K
- Legal & General Investment Management America sold 1.11K sh · $3.03K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|
| AQR Capital Management | — | — | — | — | — | — | 27.11K | 127.49K |
| Geode Capital Management | 27.89K | 27.89K | 33.49K | 118.05K | 145.41K | 207.74K | 228.33K | 112.55K |
| Millennium Management | — | — | 12.19K | — | — | — | — | 96.68K |
| BlackRock Inc | — | 7.75K | 7.60K | 195.45K | 282.07K | 432.04K | 427.15K | 90.03K |
| Goldman Sachs Group | — | 11.25K | 22.36K | — | — | — | 12.41K | 35.50K |
| Northern Trust Corp | — | — | 53.85K | 85.69K | 85.45K | 101.42K | 97.85K | 21.22K |
| Deutsche Bank AG | — | — | — | 10.44K | 1.26K | 9.31K | 36.40K | 12.23K |
| JPMorgan Chase & Co | — | 3 | — | 2.78K | 2.48K | 3.79K | — | 7.63K |
| UBS Group AG | — | 1.93K | 1.98K | 2.35K | 8.93K | 5.12K | 1.95K | 3.53K |
| Morgan Stanley | — | 542 | 1.54K | 7.74K | 7.63K | 13.12K | 6.88K | 3.49K |
| Fidelity Management & Research (FMR) | — | — | — | 311 | 573 | 280 | 8.95K | 3.29K |
| PNC Financial Services | — | — | — | — | 384 | — | 17 | 2.51K |
| Wells Fargo & Co | 3.39K | — | — | 12.80K | 13.54K | 20.15K | 5.89K | 2.45K |
| Citigroup Inc | 10.97K | 2 | 649 | 2.09K | 260 | 215 | 498 | 395 |
| Bank of America Corp | 23 | 24 | 25 | 15.29K | 4.87K | 9.06K | 11.03K | — |
| BNY Mellon | — | — | — | — | — | 12.56K | 15.42K | — |
| Legal & General Investment Management America | — | — | — | 708 | 708 | 1.28K | 1.11K | — |
| Charles Schwab Investment Management | — | — | — | 14.77K | 14.77K | 23.84K | 11.15K | — |
| Vanguard Group | — | 14.30K | 18.57K | 264.46K | 316.01K | 529.11K | — | — |
| Citadel Advisors | — | — | 14.19K | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details